SAS MEDICS LIMITED
Executive Summary
SAS MEDICS LIMITED exhibits a stable and improving financial condition characterized by strong liquidity and growing net assets. The company is well-positioned operationally within its micro-entity scale, with no immediate financial distress symptoms. Continued prudent financial management and strategic growth planning will support sustained financial wellness.
View Full Analysis Report →Company Documents
| Date | Description |
|---|---|
| 24/02/2524 February 2025 | Confirmation statement made on 2025-02-24 with updates |
| 20/01/2520 January 2025 | Micro company accounts made up to 2024-04-30 |
| 07/05/247 May 2024 | Confirmation statement made on 2024-04-20 with no updates |
| 30/04/2430 April 2024 | Annual accounts for year ending 30 Apr 2024 |
| 21/06/2321 June 2023 | Micro company accounts made up to 2023-04-30 |
| 09/05/239 May 2023 | Confirmation statement made on 2023-04-20 with no updates |
| 30/04/2330 April 2023 | Annual accounts for year ending 30 Apr 2023 |
More Company Information
Recently Viewed
Follow Company
- Receive an alert email on changes to financial status
- Early indications of liquidity problems
- Warns when company reporting is overdue
- Free service, no spam emails Follow this company